Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways
Abstract Inflammatory bowel disease (IBD) is closely linked to the homeostasis of the intestinal environment, and exosomes can be used to treat IBD due to their high biocompatibility and ability to be effectively absorbed by the intestinal tract. However, Ginseng-derived nanoparticles (GDNPs) have n...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
BMC
2024-02-01
|
| 叢編: | Journal of Nanobiotechnology |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1186/s12951-024-02313-x |